Drug General Information
Drug ID
D0GX3L
Former ID
DNCL003540
Drug Name
Arbaclofen placarbil
Synonyms
AP; R-baclofen - XenoPort; XP-19986
Drug Type
Small molecular drug
Indication Fragile X syndrome [ICD9: 332, 759.83; ICD10:F02.3, G20, Q99.2] Phase 3 [523413]
Company
Genentech
Structure
Download
2D MOL

3D MOL

Formula
C19H26ClNO6
Canonical SMILES
C1=CC(=CC=C1C(CC(=O)O)CN)Cl
InChI
1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1
InChIKey
KPYSYYIEGFHWSV-QMMMGPOBSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) GABA B receptor Target Info Modulator
References
Ref 523413ClinicalTrials.gov (NCT01325220) Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.